Maybe "path to market" means no UK approval withou
Post# of 148175
(Total Views: 704)
Posted On: 09/07/2020 10:18:24 PM
Maybe "path to market" means no UK approval without supply.
UK MHRA could play a little gambit of its own.
MHRA may have already decided to approve LL for severe/critical based on EIND and Patterson.
Might the UK offer: "We will approve LL for severe/critical if you can guarantee us ______ supply".
UK MHRA could play a little gambit of its own.
MHRA may have already decided to approve LL for severe/critical based on EIND and Patterson.
Might the UK offer: "We will approve LL for severe/critical if you can guarantee us ______ supply".
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼